Contact this trialFirst, we need to learn more about you.
Leukotriene Inhibitor
MN-001 for Non-alcoholic Fatty Liver Disease
Recruiting0 awardsPhase 2
Las Vegas, Nevada
This trial will test whether the drug MN-001 (tipelukast) is effective in reducing liver fat content and fasting serum triglycerides in patients, compared to placebo. The trial will also assess the safety and tolerability of the drug.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service